Humoral immune responses to a protective peptide-conjugate against measles after different prime-boost regimens
- 22 October 2004
- Vol. 22 (31-32) , 4173-4182
- https://doi.org/10.1016/j.vaccine.2004.06.013
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The rationale of a peptide-conjugate vaccine against measlesVaccine, 2003
- Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in miceEuropean Journal of Immunology, 1998
- Priming with diphtheria-tetanus-pertussis vaccine enhances the response to the Haemophilus influenzae type b tetanus conjugate vaccine in infancyVaccine, 1996
- Passively acquired anti-tetanus and anti-Haemophilus antibodies and the response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infancyThe Pediatric Infectious Disease Journal, 1996
- Comparison of five different vaccination schedules with Haemophilus influenzae type b-tetanus toxoid conjugate vaccineThe Journal of Pediatrics, 1996
- Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infantsJAMA, 1994
- Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccineThe Journal of Pediatrics, 1992
- Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of ageThe Lancet, 1992
- EFFECT OF PRIMING WITH CARRIER ON RESPONSE TO CONJUGATE VACCINEThe Lancet, 1989
- Carrier-priming leads to hapten-specific suppressionNature, 1980